Solventum Corp (SOLV)
| Market Cap | $14.58B+11.9% |
| Revenue (ttm) | $8.16B |
| Net Income | $156.00M |
| EPS | $0.89 |
| Shares Out | 169.96M |
| PE Ratio | 96.40 |
| Forward PE | 11.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 786,479 |
| Open | $86.06 |
| Previous Close | $86.48 |
| Day's Range | $84.37 - $87.18 |
| 52-Week Range | $62.38 - $94.16 |
| Beta | 0.75 |
| Analysts | Buy |
| Price Target | $98.38(+14.67%) |
| Earnings Date | Nov 5, 2026 |
About SOLV
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
$SOLV stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of SOLV by members of U.S. Congress
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| French HillHouse / R | Sale$15.00K – $50.00K | Dec 31, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Jan 15, 2025 |
| Gary C. PetersSenate / D | Sale$1.00K – $15.00K | May 14, 2024 |
Recently reported changes in SOLV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by SOLV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
SOLV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SOLV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SOLV from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from SOLV’s recent data — informational, not investment advice
What’s Behind the Score
News check: No concrete SOLV-specific news found; most headlines are opinion pieces or market forecasts mentioning competitors without direct company catalyst.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| CSD | Invesco S&P Spin-Off ETF | 4.61% |
| FHH.TO | First Trust AlphaDEX U.S. Health Care Sector Index ETF | 2.29% |
| FXH | First Trust Health Care AlphaDEX Fund | 2.28% |
| DUSA | Davis Select U.S. Equity ETF | 2.28% |
| LPSV | Lone Peak SMID Value ETF | 2.18% |
| DWLD | Davis Select Worldwide ETF | 2.00% |
| PZLV | Pzena U.S. Large Cap Value ETF | 1.95% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 1.50% |
| RYH | Invesco S&P 500 Equal Weight Health Care ETF | 1.44% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 1.44% |
| ZUH.TO | BMO Equal Weight US Health Care Hedged to CAD Index ETF | 1.02% |
| ZHU.TO | BMO Equal Weight US Health Care Index ETF | 1.00% |
Weight is the stock’s share of each fund’s holdings.
